Carregant...
A patent review of the ubiquitin ligase system: 2015-2018
INTRODUCTION: Ubiquitin-Proteasome System (UPS) has been validated as a novel anticancer drug target in the past 20 years. The UPS contains two distinct steps: ubiquitination of a substrate protein by ubiquitin activating enzyme (E1), ubiquitin conjugating enzyme (E2), and ubiquitin ligase (E3), and...
Guardat en:
| Publicat a: | Expert Opin Ther Pat |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6398165/ https://ncbi.nlm.nih.gov/pubmed/30449221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2018.1549229 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|